Iranian Red Crescent Medical Journal

Published by: Kowsar

Anti-Proliferative Effects of Two New Lactobacillus Strains of Human Origin on Caco-2 Cell Line

Simin Arian 1 , Hami Kaboosi 1 , * , Zaheir Heshmatipour 2 , Zeinab Khazaei Koohpar 3 and Fatemeh Pyravii-Ghadikolaii 4
Authors Information
1 Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
2 Department of Microbiology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
3 Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
4 Department of Microbiology, Ghaemshahr Branch, Islamic Azad University, Ghaemshahr, Iran
Article information
  • Iranian Red Crescent Medical Journal: March 31, 2019, 21 (3); e84683
  • Published Online: March 18, 2019
  • Article Type: Research Article
  • Received: September 27, 2018
  • Revised: March 3, 2019
  • Accepted: March 5, 2019
  • DOI: 10.5812/ircmj.84683

To Cite: Arian S, Kaboosi H, Heshmatipour Z , Khazaei Koohpar Z, Pyravii-Ghadikolaii F. Anti-Proliferative Effects of Two New Lactobacillus Strains of Human Origin on Caco-2 Cell Line, Iran Red Crescent Med J. 2019 ; 21(3):e84683. doi: 10.5812/ircmj.84683.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Zabala A, Martin MR, Haza AI, Fernandez L, Rodriguez JM, Morales P. Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line. Lett Appl Microbiol. 2001;32(4):287-92. [PubMed: 11298943].
  • 2. Evivie SE, Huo GC, Igene JO, Bian X. Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics. Food Nutr Res. 2017;61(1):1318034. doi: 10.1080/16546628.2017.1318034. [PubMed: 28659729]. [PubMed Central: PMC5475324].
  • 3. Uccello M, Malaguarnera G, Basile F, D'Agata V, Malaguarnera M, Bertino G, et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 2012;12 Suppl 1. S35. doi: 10.1186/1471-2482-12-S1-S35. [PubMed: 23173670]. [PubMed Central: PMC3499195].
  • 4. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, et al. Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One. 2016;11(2). e0147960. doi: 10.1371/journal.pone.0147960. [PubMed: 26849051]. [PubMed Central: PMC4744000].
  • 5. Motevaseli E, Dianatpour A, Ghafouri-Fard S. The role of probiotics in cancer treatment: Emphasis on their in vivo and in vitro anti-metastatic effects. Int J Mol Cell Med. 2017;6(2):66-76. doi: 10.22088/acadpub.BUMS.6.2.1. [PubMed: 28890883]. [PubMed Central: PMC5581548].
  • 6. Abedin-Do A, Taherian-Esfahani Z, Ghafouri-Fard S, Ghafouri-Fard S, Motevaseli E. Immunomodulatory effects of Lactobacillus strains: Emphasis on their effects on cancer cells. Immunotherapy. 2015;7(12):1307-29. doi: 10.2217/imt.15.92. [PubMed: 26595390].
  • 7. Thirabunyanon M, Boonprasom P, Niamsup P. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett. 2009;31(4):571-6. doi: 10.1007/s10529-008-9902-3. [PubMed: 19116692].
  • 8. Kahouli I, Tomaro-Duchesneau C, Prakash S. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J Med Microbiol. 2013;62(Pt 8):1107-23. doi: 10.1099/jmm.0.048975-0. [PubMed: 23558140].
  • 9. Oke S, Martin A. Insights into the role of the intestinal microbiota in colon cancer. Therap Adv Gastroenterol. 2017;10(5):417-28. doi: 10.1177/1756283X17694832. [PubMed: 28507600]. [PubMed Central: PMC5415097].
  • 10. Gao R, Gao Z, Huang L, Qin H. Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis. 2017;36(5):757-69. doi: 10.1007/s10096-016-2881-8. [PubMed: 28063002]. [PubMed Central: PMC5395603].
  • 11. Çakır İ. Determination of some probiotic properties on Lactobacilli and Bifidobacteria [disseration]. Turkey: Ankara University; 2003.
  • 12. Roos S, Engstrand L, Jonsson H. Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int J Syst Evol Microbiol. 2005;55(Pt 1):77-82. doi: 10.1099/ijs.0.63083-0. [PubMed: 15653856].
  • 13. Mojgani N, Hussaini F, Vaseji N. Characterization of indigenous lactobacillus strains for probiotic properties. Jundishapur J Microbiol. 2015;8(2). e17523. doi: 10.5812/jjm.17523. [PubMed: 25793099]. [PubMed Central: PMC4353062].
  • 14. Fredriksson NJ, Hermansson M, Wilen BM. The choice of PCR primers has great impact on assessments of bacterial community diversity and dynamics in a wastewater treatment plant. PLoS One. 2013;8(10). e76431. doi: 10.1371/journal.pone.0076431. [PubMed: 24098498]. [PubMed Central: PMC3788133].
  • 15. Paolillo R, Romano Carratelli C, Sorrentino S, Mazzola N, Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol. 2009;9(11):1265-71. doi: 10.1016/j.intimp.2009.07.008. [PubMed: 19647100].
  • 16. Subhashini S, Lavanya J, Meignanalakshmi S. In vitro studies on adhesion and the effect of cytotoxicity of bifidobacterium spp. using cell lines. Eur Sci J. 2013;9(18):1857–7881. doi: 10.19044/esj.2013.v9n18p%25p.
  • 17. de Andrade Calaca PR, Bezerra RP, Albuquerque WWC, Porto ALF, Cavalcanti MTH. Probiotics as a preventive strategy for surgical infection in colorectal cancer patients: A systematic review and meta-analysis of randomized trials. Transl Gastroenterol Hepatol. 2017;2:67. doi: 10.21037/tgh.2017.08.01. [PubMed: 28905008]. [PubMed Central: PMC5590023].
  • 18. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, et al. Cancer-preventing attributes of probiotics: An update. Int J Food Sci Nutr. 2010;61(5):473-96. doi: 10.3109/09637480903455971. [PubMed: 20187714].
  • 19. Orlando A, Linsalata M, Russo F. Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG. Int J Oncol. 2016;48(6):2629-38. doi: 10.3892/ijo.2016.3463. [PubMed: 27035094].
  • 20. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci. 1995;78(3):491-7. doi: 10.3168/jds.S0022-0302(95)76659-0. [PubMed: 7782506].
  • 21. Lee DK, Jang S, Kim MJ, Kim JH, Chung MJ, Kim KJ, et al. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer. 2008;8(1). doi: 10.1186/1471-2407-8-310.
  • 22. Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol. 2006;42(5):452-8. doi: 10.1111/j.1472-765X.2006.01913.x. [PubMed: 16620202].
  • 23. Ewaschuk JB, Walker JW, Diaz H, Madsen KL. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr. 2006;136(6):1483-7. doi: 10.1093/jn/136.6.1483. [PubMed: 16702308].
  • 24. Chen CC, Lin WC, Kong MS, Shi HN, Walker WA, Lin CY, et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr. 2012;107(11):1623-34. doi: 10.1017/S0007114511004934. [PubMed: 21992995].
  • 25. Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, et al. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016;83:536-41. doi: 10.1016/j.biopha.2016.07.001. [PubMed: 27447122].
  • 26. Gayathri D; Asha. Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice. Exp Ther Med. 2012;3(6):1049-54. doi: 10.3892/etm.2012.536. [PubMed: 22970015]. [PubMed Central: PMC3438560].
  • 27. Kahouli I, Malhotra M. Identification of lactobacillus fermentum strains with potential against colorectal cancer by characterizing short chain fatty acids production, anti-proliferative activity and survival in an intestinal fluid: In vitro analysis. J Bioanalysis Biomed. 2015;7(4). doi: 10.4172/1948-593x.1000132.
  • 28. Er S, Koparal AT, KivanÇ M. Cytotoxic effects of various lactic acid bacteria on Caco-2 cells. Turk J Biol. 2015;39:23-30. doi: 10.3906/biy-1402-62.
  • 29. Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci. 2014;17(10):815-9. [PubMed: 25729553]. [PubMed Central: PMC4340992].
  • 30. Thirabunyanon M, Hongwittayakorn P. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol. 2013;169(2):511-25. doi: 10.1007/s12010-012-9995-y. [PubMed: 23239414].
  • 31. Verdenelli MC, Ghelfi F, Silvi S, Orpianesi C, Cecchini C, Cresci A. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr. 2009;48(6):355-63. doi: 10.1007/s00394-009-0021-2. [PubMed: 19365593].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments